These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6026796)

  • 1. [What does L-Dopa accomplish in the treatment of Parkinson akinesis?].
    Umbach W; Aebert K
    Dtsch Med Wochenschr; 1967 Jul; 92(27):1241-3. PubMed ID: 6026796
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of L-DOPA on the akinesis in Parkinson's syndrome].
    Bischoff A
    Schweiz Med Wochenschr; 1967 Sep; 97(35):1158-9. PubMed ID: 5593650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current treatment of Parkinson syndrome with L-dopa].
    Gerstendbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical electroencephalographic studies during the treatment of parkinsonism with an L-DOPA preparation].
    Krasnov EA; Romenskaia LKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):520-3. PubMed ID: 4705406
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of L-dopa on the EEG and EMG in Parkinson patients.
    Visser SL; Postma JU
    Psychiatr Neurol Neurochir; 1971; 74(4):315-21. PubMed ID: 5146237
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the effects of L-dopa during a 3-month course of treatment].
    Pinto F; Venturini E
    Riv Neurobiol; 1970; 16(4):415-28. PubMed ID: 4949926
    [No Abstract]   [Full Text] [Related]  

  • 7. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 8. Electroencephalographic changes occurring during L-dopa treatment.
    Herman MN; Rowan AJ; Goldensohn ES
    Trans Am Neurol Assoc; 1971; 96():252-4. PubMed ID: 5159096
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Arterial pressure and cerebral blood flow in parkinsonian patients treated with L Dopa. Their postural regulation].
    Boismare F; Samson M; Brouta M
    Nouv Presse Med; 1973 Oct; 2(38):2552. PubMed ID: 4763463
    [No Abstract]   [Full Text] [Related]  

  • 10. [L-dopa in Parkinson's syndrome].
    Filho RM; de Karam GM
    Rev Bras Med; 1971 May; 28(5):220-31. PubMed ID: 5563096
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of L-DOPA on sleep spindles in patients with parkinsonism].
    Bricolo A; Sciarretta G; Mazza C; Turella G
    Riv Sper Freniatr Med Leg Alien Ment; 1970 Apr; 94(2):416-24. PubMed ID: 4320855
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
    Danielczyk W; Korten JJ
    Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
    [No Abstract]   [Full Text] [Related]  

  • 13. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa].
    Paci A; Freddi A; Barba C
    Riv Neurol; 1973; 43(1):15-39. PubMed ID: 4698011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes].
    Puca FM; Bricolo A; Turella G
    Rev Neurol (Paris); 1972 Aug; 127(2):313. PubMed ID: 4666639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
    Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A
    Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743
    [No Abstract]   [Full Text] [Related]  

  • 16. EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.
    Marjerrison G; Boulton AA; Rajput AH
    Dis Nerv Syst; 1972 Mar; 33(3):164-9. PubMed ID: 5022451
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in nocturnal sleep in parkinsonism patients treated with L-dopa].
    Bricolo A; Turella G; Mazza CA; Buffatti P; Grosslercher JC
    Sist Nerv; 1970; 22(2):181-90. PubMed ID: 4323416
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Guillard A
    Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinson's disease by L-DOPA].
    Barbeau A
    Union Med Can; 1969 Feb; 98(2):183-6. PubMed ID: 5773394
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-dopa in the treatment of Parkinson's disease].
    Völler G
    Med Welt; 1970 Jul; 27():1267-8. PubMed ID: 5512643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.